Processa Pharmaceuticals, Inc. Crypto Asset Purchase
Processa Pharmaceuticals, Inc. (PCSA) reported Crypto Asset Purchase of $500.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Goodwill and Other
us-gaap:CryptoAssetPurchase · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. crypto asset purchase for the quarter ending 2026-06-30 was $0.00.
- Processa Pharmaceuticals, Inc. crypto asset purchase for the quarter ending 2026-03-31 was $500.00K.
- Processa Pharmaceuticals, Inc. crypto asset purchase for fiscal 2025 was $850.00K.
| Period end | Crypto Asset Purchase 3 month | Crypto Asset Purchase 6 month | Crypto Asset Purchase 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $500.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $850.00K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |